Navigation Links
Chronic jet-lag conditions hasten death in aged mice

Researchers have found that aged mice undergoing weekly light-cycle shifts--similar to those that humans experience with jet lag or rotating shift work--experienced significantly higher death rates than did old mice kept on a normal daylight schedule over the same eight-week period. The findings may not come as a great surprise to exhausted globe-trotting business travelers, but the research nonetheless provides, in rather stark terms, new insight into how the disruption of circadian rhythms can impact well-being and physiology, and how those impacts might change with age. The mouse study is reported by a group led by Gene Block and Alec Davidson of the University of Virginia and appears in the November 7th issue of the journal Current Biology, published by Cell Press.

The researchers were led to examine a possible link between jet lag and mortality by something they had noticed in an earlier, unrelated study: A surprising fraction of old (but genetically altered) rats exposed to a six-hour advance in their light cycle died after the shift in schedule.

In the new work, the researchers examined the mortality link in earnest by looking at how young mice and old mice fared when subjected to two different types of light-cycle shifts. In one regimen, mice experienced a six-hour forward shift once a week, while in the other, mice experienced a six-hour backward shift. A "control" group of young and old mice did not experience any schedule shifts.

The researchers found that the young mice generally survived well under the various conditions. In contrast, the light-cycle shifts had a marked effect on the survivorship of the old mice. While 83% of old mice survived under the normal schedule, 68% survived under the backward-shift regimen and 47% survived under the forward-shift regimen.

Past work has also linked changes in light schedule with death in other animals and under different experimental circumstances, but the findings here indic
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain
2. Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show Its Snot
3. FDA Approves New Treatment for Chronic Hepatitis B
4. Chronic pain up almost 40 percent among US workers in past decade
5. Chronic fatigue syndrome impairs a persons slow wave activity during sleep
6. Plant genes identified that can form basis for crops better adapted to environmental conditions
7. Life in deadly conditions
8. UF scientists test improved gene therapy method for hereditary heart conditions
9. Food-crop yields in future greenhouse-gas conditions lower than expected
10. How badger culling creates conditions for spread of bovine TB
11. Study challenges myth that sex late in pregnancy hastens birth
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chronic jet lag conditions hasten death aged mice

(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... scientific basis for eventual treatment, neurology researchers have shown ... protein that helps keep brain activity in balance. The ... an underlying reason for seizures and memory defects experienced ... (TBI). , "A traumatic brain injury occurs to someone ...
... an immune response against HIV, research funded by the Wellcome ... in the US has found that bigger is not necessarily ... a profound impact on the development of a vaccine against ... bigger the immune response, the more effective it will be ...
... Scientists have discovered that autoimmunity can be triggered in the ... cells fail to recognize just one of the body's thousands ... view that autoimmunity can start in this cradle of the ... diseases emerge, such as the pancreas in the case of ...
Cached Biology News:How brain injury leads to seizures, memory problems 2Quality not quantity important for immune response to HIV 2Autoimmune disease triggered if T cells miss a single protein early on 2Autoimmune disease triggered if T cells miss a single protein early on 3
(Date:7/6/2015)... , July 6, 2015  Emdeon Inc. ... a definitive agreement to acquire Altegra Health, ... platforms that combine data aggregation and analytics ... to achieve actionable insights and improved management ... Altegra Health,s risk adjustment and quality analytics ...
(Date:7/6/2015)... 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company focused ... Viveve,s Chief Executive Officer, and Scott Durbin , Viveve,s ... 9, 2015. , , , DATE:    , ... , TIME:     , , , 12:15 PM EDT ... http://tinyurl.com/viveve   ,    ...
(Date:7/5/2015)... ... 06, 2015 , ... For many years, metal-on-quartz filters were the industry standard ... as a Varian Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu 3600-3700, these ... used them for their SRM-2031 series going back for many years. Unfortunately, these standards ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... by Fortune 500 companies and professional service industries alike-- typically known for its ... clients laugh, honor a good cause and break from their day jobs. , ...
Breaking Biology Technology:Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3The Alexander Group Declares Their Independence with a Bit of Levity 2
... , , SOUTH SAN FRANCISCO, ... today announced that 320 evaluable events (patient deaths) have occurred in its ... is being conducted in accordance with a Special Protocol Assessment (SPA) with ... of small cell lung cancer (SCLC). , , ...
... WOBURN, Mass., Sept. 15 BioVex Inc, a biotechnology ... infectious disease, announced today that the U.S. Food and Drug Administration ... clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line ... neck. , , The study is the ...
... , SAN DIEGO, Sept. 15 ... with China, today announced a strategic partnership agreement with Guangzhou ... HUYA has established a series of strategic partnerships with Chinese ... portfolio of novel biopharmaceutical products. The agreement with GIBH provides ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 5BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 4HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 2HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 3
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
WIF-1 (N-20)...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
Biology Products: